Hermes Ryoiti Higashino

6PUBLICATIONS
29CO-AUTHORS
Major global burdens of diseaseCancer therapy (excl. chemotherapy and radiation therapy)Cardiovascular medicine and haematology not elsewhere classifiedRespiratory diseasesMedical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 05, 2026
Fatal transfusion-transmitted severe dengue in an immunocompromised host: case report and systematic literature review.

|Jun 04, 2025
Quantitative PCR for parasitemia monitoring and preemptive therapy in patients with Chagas disease and autoimmune rheumatic disorders undergoing biologic treatment: a case series.

Noemia Barbosa Carvalho, Vera Lucia Teixeira de Freitas, Nadia Emi Aikawa

|Feb 21, 2025
COVID-19 prior to hematopoietic stem cell transplantation increases the risk of acute graft-versus-host disease but does not affect overall mortality.

Bruno Azevedo Randi, Hermes Ryoiti Higashino, Vinícius Ponzio

|Oct 26, 2022
Aplastic Anemia and Chagas Disease: T. cruzi Parasitemia Monitoring by Quantitative PCR and Preemptive Antiparasitic Therapy.

Noêmia Barbosa Carvalho, Vera Teixeira de Freitas, Rita Cristina Bezerra

|Sep 23, 2022
Impact of Discontinuing Levofloxacin Prophylaxis on Bloodstream Infections in Neutropenic Hematopoietic Stem Cell Transplantation Patients.

Thaís Guimarães, Igor Carmo Borges, Fernanda de Souza Spadão

|Dec 04, 2018
Colistin-resistant Klebsiella pneumoniae co-harboring KPC and MCR-1 in a Hematopoietic Stem Cell Transplantation Unit.

Hermes Ryoiti Higashino, Ana Paula Marchi, Roberta Cristina Ruedas Martins

Pageof 1